Early stage IT and Healthcare Investing

Neuronetics

portfoliocompanies

company snapshot

Neuronetics

Neuronetics is a medical device company focused on developing non-invasive therapies for psychiatric and neurological disorders using MRI-strength magnetic field pulses. It is the first and only company to have a non-systemic and non-invasive depression treatment cleared by the FDA for patients who have not benefited from prior antidepressant treatment.

website
www.neuronetics.com
Leadership
Follow The Company
Investment Team
Chris Thatcher, President & CEO
Facebook Google+ Twitter Email LinkedIn Share